The global liquid biopsy market is projected to reach USD 21.78 billion by 2032.
From GlobeNewswire: 2025-03-20 10:37:00
The global liquid biopsy market, valued at USD 7.20 billion in 2023, is projected to reach USD 21.78 billion by 2032, growing at a CAGR of 13.11%. Liquid biopsy allows early cancer detection and personalized treatment. Advances in technology like NGS have enhanced the market, with North America leading in adoption due to high cancer rates and technological advancements.
In 2023, instruments dominated the market with a 47.1% share, crucial for accurate tests. Kits and reagents are expected to grow rapidly due to their convenience and efficiency. Multi-gene parallel analysis, including NGS, led the market, while single-gene analysis is set for strong growth. Liquid biopsy offers various applications in cancer and reproductive health, with hospitals and labs being the primary end-users.
North America held the largest market share in 2023 at 52.3%, driven by high cancer rates and technological advancements. The Asia-Pacific region is expected to grow rapidly due to healthcare reforms and a growing aging population. Initiatives in countries like China and India for free cancer screening programs will boost the demand for liquid biopsy tests. In January 2025, Oxford Cancer Analytics secured $11 million in funding to advance early lung cancer detection. Mayo Clinic Laboratories partnered with Lucence to offer LiquidHallmark liquid biopsy technology globally, expanding access to liquid biopsy solutions. The liquid biopsy market is expected to grow in the Asia-Pacific region due to collaborations between government, institutes, and companies.
The liquid biopsy market report covers key points such as market dynamics, statistical insights, competitive landscape, and regional analysis. It also includes sections on market trends, product types, technologies, sample types, biomarkers, applications, clinical applications, end-users, company profiles, and best practices. SNS Insider is a leading market research and consulting agency providing clients with accurate market data to make informed decisions in changing circumstances.
Read more at GlobeNewswire: Liquid Biopsy Market Projected to Reach USD 21.78 Billion